(Q41556925)

3 October 2017

0 references

0 references

Advances in gout: some answers, more questions (English)

1 reference

3 October 2017

Jasvinder A Singh

1

0 references

publication date

24 September 2010

1 reference

Arthritis Research and Therapy

3 October 2017

1 reference

3 October 2017

12

1 reference

3 October 2017

5

1 reference

3 October 2017

136

1 reference

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

3 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2990989

Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2990989

Long-term cardiovascular mortality among middle-aged men with gout

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2990989

Gout and the risk of acute myocardial infarction

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2990989

Febuxostat compared with allopurinol in patients with hyperuricemia and gout

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2990989

Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2990989

A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2990989

Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2990989

Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2990989

Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2990989

Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2990989

Opportunities for improving medication use and monitoring in gout.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2990989

J-Shaped Relation Between Blood Pressure and Stroke in Treated Hypertensives

19 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20959031

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Gout medication treatment patterns and adherence to standards of care from a managed care perspective

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20959031

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Blood pressure targets after high-risk myocardial infarction: is it time to update the guidelines?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20959031

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/AR3110

1 reference

PMC publication ID

2990989

Dimensions Publication ID

3 October 2017

0 references

1 reference

PMC publication ID

2990989

3 October 2017

PubMed publication ID

20959031

1 reference

PMC publication ID

2990989